Life Insurance  

How cancer screening might affect your clients' premiums

"On balance, it is still too early to know how MCEDs will pan out, and insurers and reinsurers will need to adapt their products, pricing and underwriting and claims approaches as developments unfold."    

 

Article continues after advert

simoney.kyriakou@ft.com